NIH-funded research R01 grant

How heat‑producing (thermogenic) fat cells are controlled

Official title: Transcriptional and epigenetic regulation of thermogenic adipocyte program

Funded at Joslin Diabetes Center · NIH-11323140 · Data updated 2026-11-12

This project looks at the molecular switches that turn on calorie‑burning fat cells to help people with obesity and related metabolic problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 6, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$602,295
NIH project number5R01DK132469-05
Project IDNIH-11323140 on NIH RePORTER

Who could benefit from this research

Could help

People with obesity, insulin resistance, or other metabolic conditions would be the most relevant candidates for related clinical studies or future therapies.

Less likely to help

Individuals without metabolic or obesity‑related conditions or those needing immediate medical treatment are unlikely to see direct benefit from this basic research in the short term.

What this research studies

From my perspective as a patient, the team is using modern gene‑editing screens (CRISPR) and chromatin mapping methods to find proteins and DNA features that control brown and beige fat cells. They are following up on a key histone variant called H2A.Z and studying how chromatin folding affects thermogenic genes like UCP1. Work will combine lab studies in cells and model systems with analysis of human‑relevant tissue features to identify targets that could be turned into therapies. The goal is to understand controllable switches that boost the body’s natural energy‑burning fat.

Why it matters

Potential benefit: If successful, this work could point to new treatments that activate thermogenic fat to increase calorie burning and lower risks of diabetes and heart disease.

How similar studies have gone: Prior research links active brown fat to better metabolism and some interventions (cold exposure, beta‑adrenergic stimulation) can activate thermogenesis, but targeting epigenetic regulators like H2A.Z is a newer, less tested approach.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Tseng, Yu-Hua — Joslin Diabetes Center
  • Study coordinator: Tseng, Yu-Hua

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.